학술논문

ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy
Document Type
Article
Source
In: Lung Cancer. (Lung Cancer, August 2012, 77(2):421-426)
Subject
Language
English
ISSN
01695002
18728332